Osseous changes and abnormalities of mineral metabolism in rats with glycopeptide-induced nephritis.
A laboratory model of renal osteodystrophy was developed in rats by a single injection of glycopeptide isolated from renal cortical tissues of rats according to the method used by Shibata et al. to induce glomerulonephritis. Approximately 60-70 days after injection, severe proteinuria appeared and continued for at least 170 days at a rate of more than 1 g/day. Morphological changes in the kidney were typical of chronic glomerulonephritis. The plasma calcium concentration was lowered transiently by the 96th day after injection, but was restored to the normal range thereafter. Plasma parathyroid hormone levels, however, continued to rise in parallel with the degree of proteinuria. Marked secondary hyperparathyroidism was induced which led to severe bone atrophy. Histological examinations showed a marked increase of resorbing cavities, with a quantitatively larger number of osteoclasts in cortical bone tissues compared with the control animals. No spontaneous remission was observed. It is emphasized that all of the biochemical and morphological changes reported here were induced by a single injection of homologous renal glycopeptide, and they were highly reproducible.
D000818:Animals; D001842:Bone and Bones / Q000473:pathology; D002118:Calcium / Q000378:metabolism*; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000378:metabolism*; D004195:Disease Models, Animal; D006020:Glycopeptides / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D009393:Nephritis / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D010280:Parathyroid Glands / Q000473:pathology; D011507:Proteinuria; D051381:Rats
D006020:Glycopeptides; D002118:Calcium